Medicare Enrolled
Dr. Anu Dham, MD
Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dham
Dr. Anu Dham is a hematology & oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dham performed 37,352 Medicare services across 1,770 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dham received a total of $12,339 from 70 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in TX
$12,339 industry payments
Medicare Practice Summary
Medicare Utilization ↗37,352
Medicare services
Top 26% in TX for hematology & oncology
1,770
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,966 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 10,200 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 8,250 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia | 8,215 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 1,801 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,792 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 960 | $18 | $66 |
| Injection, fluorouracil, 500 mg | 703 | $2 | $13 |
| Anti-nausea injection (Aloxi/palonosetron) | 630 | $1 | $114 |
| Complete blood count (CBC) with differential | 506 | $8 | $36 |
| Comprehensive metabolic blood panel | 487 | $10 | $64 |
| Office visit, established patient (30-39 min) | 452 | $91 | $368 |
| Blood draw (venipuncture) | 447 | $8 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 282 | $20 | $157 |
| Flow cytometry, additional marker | 276 | $18 | $180 |
| Injection, zoledronic acid, 1 mg | 252 | $7 | $431 |
| Office visit, established patient (20-29 min) | 237 | $62 | $250 |
| Administration of chemotherapy into vein, 1 hour or less | 176 | $93 | $707 |
| Immunoglobulin level test | 156 | $9 | $56 |
| Drug injection, under skin or into muscle | 137 | $11 | $96 |
| Measurement of immunoglobulin light chains | 130 | $17 | $60 |
| Hospital follow-up visit, moderate complexity | 111 | $58 | $247 |
| Carcinoembryonic antigen (cea) protein level | 103 | $18 | $99 |
| Ferritin level test (iron stores) | 92 | $13 | $60 |
| Iron level test | 92 | $6 | $27 |
| Iron binding capacity test | 92 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 86 | $44 | $313 |
| Administration of chemotherapy into vein, each additional hour | 67 | $19 | $161 |
| Administration of additional new drug or substance into vein using push technique | 58 | $38 | $289 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 55 | $124 | $500 |
| Administration of additional new drug or substance into vein, 1 hour or less | 52 | $47 | $344 |
| New patient office visit (45-59 min) | 51 | $118 | $565 |
| Injection, diphenhydramine hcl, up to 50 mg | 42 | $1 | $7 |
| Microscopic examination for white blood cells with manual cell count | 34 | $4 | $22 |
| Complete blood count (CBC), automated | 34 | $6 | $34 |
| Irrigation of implanted venous access drug delivery device | 34 | $17 | $114 |
| Lactate dehydrogenase (enzyme) level | 31 | $6 | $31 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 31 | $272 | $2,762 |
| New patient office visit, complex (60-74 min) | 30 | $152 | $709 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 21 | $178 | $700 |
| Ct scan of chest with contrast | 20 | $46 | $821 |
| Initial hospital admission, moderate complexity | 19 | $93 | $470 |
| CT scan of abdomen and pelvis with contrast | 17 | $171 | $1,067 |
| Folic acid level test | 14 | $14 | $73 |
| Protein measurement, serum | 14 | $11 | $99 |
| Immunologic analysis technique on serum (immunofixation) | 14 | $22 | $160 |
| Vitamin B-12 level test | 13 | $15 | $76 |
| Flow cytometry technique for dna or cell analysis, first marker | 12 | $56 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
89.1% medium
9.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,339
Total received (2018-2024)
Avg $1,763/year across 7 years
Top 28% in TX for hematology & oncology
70
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,899 (55.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,817 (22.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,624 (21.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$391
2023
$263
2022
$988
2021
$1,205
2020
$1,180
2019
$4,283
2018
$4,029
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Heron Therapeutics, Inc.
$2,817
Seattle Genetics, Inc.
$2,103
Novartis Pharmaceuticals Corporation
$856
Janssen Biotech, Inc.
$586
Amgen Inc.
$554
E.R. Squibb & Sons, L.L.C.
$468
AstraZeneca Pharmaceuticals LP
$412
Eisai Inc.
$378
PFIZER INC.
$287
Merck Sharp & Dohme Corporation
$272
Alexion Pharmaceuticals, Inc.
$212
Lilly USA, LLC
$199
Incyte Corporation
$192
GENZYME CORPORATION
$175
Celgene Corporation
$156
Merck Sharp & Dohme LLC
$134
Puma Biotechnology, Inc.
$126
Myriad Genetic Laboratories, Inc.
$126
Gilead Sciences, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$118
Teva Pharmaceuticals USA, Inc.
$105
Rigel Pharmaceuticals, Inc.
$100
Astellas Pharma US Inc
$96
Genentech USA, Inc.
$88
Ipsen Biopharmaceuticals, Inc
$87
GlaxoSmithKline, LLC.
$86
Exelixis Inc.
$85
Verastem, Inc.
$80
EISAI INC.
$72
Bayer HealthCare Pharmaceuticals Inc.
$70
Karyopharm Therapeutics Inc.
$63
AbbVie, Inc.
$59
BeiGene USA, Inc.
$58
Seagen Inc.
$48
Daiichi Sankyo Inc.
$44
Clovis Oncology, Inc.
$43
Pharmacyclics LLC, An AbbVie Company
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Blueprint Medicines Corporation
$42
Kite Pharma, Inc.
$39
Dova Pharmaceuticals
$39
Helsinn Therapeutics (U.S.), Inc.
$38
Array BioPharma Inc.
$37
Regeneron Healthcare Solutions, Inc.
$36
Sobi, Inc
$34
Apellis Pharmaceuticals, Inc.
$33
MACROGENICS, INC.
$32
Deciphera Pharmaceuticals Inc.
$27
AbbVie Inc.
$27
Epizyme, Inc.,
$26
Dendreon Pharmaceuticals LLC
$26
AVEO Pharmaceuticals, Inc.
$25
SOBI, INC
$25
MorphoSys, US Inc.
$24
Sun Pharmaceutical Industries Inc.
$22
Acceleron Pharma, Inc.
$21
Advanced Accelerator Applications
$21
PUMA BIOTECHNOLOGY, INC.
$21
EMD Serono, Inc.
$20
TESARO, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
Alnylam Pharmaceuticals Inc.
$19
Biocompatibles, Inc.
$15
AMAG Pharmaceuticals, Inc.
$14
Foundation Medicine, Inc.
$14
Taiho Oncology, Inc.
$14
JAZZ PHARMACEUTICALS INC.
$14
APO-PHARMA USA, INC.
$14
Global Blood Therapeutics, Inc.
$12
Kyowa Kirin, Inc.
$11
Top 3 companies account for 46.8% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · BENDEKA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CALQUENCE · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DEFERIPRONE · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OJJAARA · ONUREG · OPDIVO · OXBRYTA · PADCEV · PIQRAY · PROMACTA · PROVENGE · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYDAPT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · Soliris · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · THERASPHERE-BIO · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · YONSA · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $33 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
BAPTIST MEDICAL CENTER
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dham is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dham experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Dham performed 10,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dham receive payments from pharmaceutical companies?
Yes. Dr. Dham received a total of $12,339 from 70 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dham's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Dham's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Antonio
Browse hematology & oncology specialists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Heron Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Heron Therapeutics, Inc.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology